- Home
- GSK vs TRI Comparison
GSK vs TRI Comparison
Compare GSK & TRI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- GSK
- TRI
- Stock Information
- Founded
- GSK 1715
- TRI 1851
- Country
- GSK United Kingdom
- TRI Canada
- Employees
- GSK N/A
- TRI N/A
- Industry
- GSK Biotechnology: Pharmaceutical Preparations
- TRI
- Sector
- GSK Health Care
- TRI
- Exchange
- GSK Nasdaq
- TRI Nasdaq
- Market Cap
- GSK 77.1B
- TRI 76.8B
- IPO Year
- GSK N/A
- TRI N/A
- Fundamental
- Price
- GSK $39.32
- TRI $171.32
- Analyst Decision
- GSK Hold
- TRI Hold
- Analyst Count
- GSK 2
- TRI 8
- Target Price
- GSK N/A
- TRI $194.50
- AVG Volume (30 Days)
- GSK 4.6M
- TRI 2.6M
- Earning Date
- GSK 07-30-2025
- TRI 08-06-2025
- Dividend Yield
- GSK 4.11%
- TRI 1.36%
- EPS Growth
- GSK N/A
- TRI N/A
- EPS
- GSK 1.13
- TRI 3.62
- Revenue
- GSK $43,336,073,439.00
- TRI $7,318,000,000.00
- Revenue This Year
- GSK $5.56
- TRI $4.17
- Revenue Next Year
- GSK $5.08
- TRI $8.03
- P/E Ratio
- GSK $16.52
- TRI $47.38
- Revenue Growth
- GSK 0.59
- TRI 4.04
- 52 Week Low
- GSK $31.72
- TRI $151.60
- 52 Week High
- GSK $44.67
- TRI $218.42
- Technical
- Relative Strength Index (RSI)
- GSK 59.10
- TRI 27.63
- Support Level
- GSK $36.75
- TRI $167.58
- Resistance Level
- GSK $39.33
- TRI $182.98
- Average True Range (ATR)
- GSK 0.66
- TRI 5.43
- MACD
- GSK 0.26
- TRI -3.14
- Stochastic Oscillator
- GSK 99.61
- TRI 10.14
About GSK GSK plc (Each representing two)
In the pharmaceutical industry, GSK ranks as one of the largest firms by total sales. The company wields its might across several therapeutic classes, including respiratory, antiviral, and vaccines, and has been growing its presence in oncology and immunology, as well. GSK uses joint ventures to gain additional scale in certain markets like HIV.
About TRI Thomson Reuters Corp
Thomson Reuters is a leading global provider of business information services, delivering trusted data, technology, and expertise to professionals across legal, tax, accounting, risk, compliance, and the news and media sectors. Headquartered in Toronto, Canada, the company combines deep domain knowledge with data and software solutions to help clients make informed decisions, manage complexity, and drive efficiency. Thomson Reuters serves legal and accounting/tax professionals, corporations, and governments worldwide, but around 75% of revenue is generated in the US. The company is known for flagship products such as Westlaw, UltraTax CS, and Reuters News.